| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.07▲ | 6.04▲ | 6.04▲ | 5.89▲ | 5.92▲ |
| MA10 | 6.04▲ | 5.91▲ | 5.91▲ | 5.84▲ | 5.99▲ |
| MA20 | 5.91▲ | 5.85▲ | 5.84▲ | 5.92▲ | 6.40▼ |
| MA50 | 5.84▲ | 5.92▲ | 5.92▲ | 6.17▼ | 6.64▼ |
| MA100 | 5.90▲ | 5.92▲ | 5.93▲ | 6.45▼ | 6.56▼ |
| MA200 | 5.93▲ | 6.31▼ | 6.37▼ | 6.72▼ | 6.28▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.024▲ | 0.039▲ | 0.040▲ | 0.032▲ | -0.045▼ |
| RSI | 64.620▲ | 61.293▲ | 60.030▲ | 54.144▲ | 46.324▼ |
| STOCH | 85.529▲ | 78.218 | 78.218 | 48.173 | 20.624 |
| WILL %R | -1.266▲ | -1.266▲ | -1.266▲ | -16.533▲ | -71.946 |
| CCI | 97.364 | 133.560▲ | 135.669▲ | 148.416▲ | -48.299 |
|
Monday, March 30, 2026 08:14 AM
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&D HACKENSACK, NJ / ACCESS Newswire / March 30, 2026 / Champions Oncology, Inc. (Nasd ...
|
|
Monday, March 30, 2026 07:56 AM
Appointment underscores Champions' focus on leveraging clinically relevant data to power next-generation oncology R&D ...
|
|
Saturday, March 14, 2026 01:03 AM
Champions Oncology, Inc. misses on earnings expectations. Reported EPS is $-0.02 EPS, expectations were $0.09. Operator: Greetings. Welcome to the Champions Oncology Third Quarter Fiscal Year 2026 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/04/26 | 5.98 | 6.125 | 5.98 | 6.12 | 1,607 |
| 06/04/26 | 5.865 | 5.95 | 5.72 | 5.89 | 4,518 |
| 02/04/26 | 5.65 | 6.02 | 5.65 | 5.77 | 2,911 |
| 01/04/26 | 5.70 | 5.9799 | 5.70 | 5.915 | 7,118 |
| 31/03/26 | 5.80 | 5.9637 | 5.75 | 5.75 | 2,916 |
| 30/03/26 | 5.70 | 5.9189 | 5.70 | 5.84 | 7,101 |
| 27/03/26 | 5.82 | 5.9015 | 5.65 | 5.74 | 11,340 |
| 26/03/26 | 5.80 | 5.845 | 5.745 | 5.79 | 8,098 |
| 25/03/26 | 5.825 | 5.875 | 5.80 | 5.80 | 7,291 |
| 24/03/26 | 5.81 | 5.9651 | 5.80 | 5.81 | 44,300 |
|
|
||||
|
|
||||
|
|